The Forkhead box C1 (FOXC1) transcription factor promotes CSC properties in basal-like breast cancer, which could activate Smo-independent Hh signalling and Gli2, and provides novel insight into anti-Hh therapy resistance in cancer progression61. This evidence concerns the gene SMO and breast cancer.